---
figid: PMC9653882__ijms-23-13015-g001
pmcid: PMC9653882
image_filename: ijms-23-13015-g001.jpg
figure_link: /pmc/articles/PMC9653882/figure/ijms-23-13015-f001/
number: Figure 1
figure_title: ''
caption: 'Puerarin-V improved the general parameters of DCM rats. (A) The body weight
  change, (B) the body weight before injection of STZ, (C) the body weight after 6
  weeks of drug treatment, (D) the oral glucose tolerance test (OGTT), (E) the area
  under the OGTT curve, (F) the liver index, (G) the lung index, (H) the spleen index,
  (I) the kidney index. The data are represented by mean ± SEM (n = 6–8). #p < 0.05
  and ##p < 0.01 vs. control group. * p < 0.05 and ** p < 0.01 vs. model group.'
article_title: Puerarin-V Improve Mitochondrial Respiration and Cardiac Function in
  a Rat Model of Diabetic Cardiomyopathy via Inhibiting Pyroptosis Pathway through
  P2X7 Receptors.
citation: Shuchan Sun, et al. Int J Mol Sci. 2022 Nov;23(21):13015.
year: '2022'

doi: 10.3390/ijms232113015
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- puerarin-V
- diabetic cardiomyopathy
- mitochondrial
- pyroptosis
- P2X7 receptors

---
